Biomedical subjects

D M Elnicki

Publications and source records attributed to D M Elnicki.

5 recordsLinked to original sources

PubMed1992

Preventing postoperative medical complications. How primary care physicians can help.

Just as your concern for your patients' welfare does not stop at the operating room door, neither does your opportunity to improve their prognosis. Drs Elnicki and Shockcor believe that primary care physicians have a unique role in total patient care. In this article, they discuss prevention of major postoperative complications and recommend ways primary care physicians can help optimize their patients' perioperative status.

Communication↗

PubMed1992

Evaluating the complaint of fatigue in primary care: diagnoses and outcomes.

PURPOSE: This case series describes associated diagnoses and prognoses of persistent fatigue in a community-based, primary care population. PATIENTS AND METHODS: All patients presenting to a private practice internist with a chief complaint of fatigue of more than 1 month's duration were prospectively evaluated with clinically directed examination and diagnostic testing. Patients were excluded if they had a previously diagnosed illness associated with fatigue. Fatigue was attributed to newly established diagnoses or medication use based on explicit criteria. Change in the state of each patient's fatigue was measured 6 months after entry. RESULTS: Fifty-two consecutive patients entered the study. The diagnoses associated with fatigue were a medical disorder in 25 patients, depression in 10 patients, and no definitive diagnosis in 18 patients. The mean cost of diagnostic testing was $131. At 6 months, 37 of 52 patients (72%) reported improvement in or resolution of their fatigue. CONCLUSION: In a primary care setting, many patients presenting with persistent fatigue have an associated, treatable disease that can be determined using a cost-effective, clinically directed approach. Most will experience an improvement in their fatigue.

Adolescent↗

PubMed1992

Hereditary angioedema.

Hereditary angioedema is a rare disease resulting from a lack of functional C1 esterase inhibitor (C1 INH). Several genetic defects can cause decreased production of the protein or the synthesis of a biologically inactive form. A similar, acquired condition is occasionally seen, associated with malignancies or as an autoimmune process. Disease severity varies greatly among affected individuals. Most patients have cutaneous, laryngeal, or gastrointestinal edema, often in combinations. The symptoms may appear spontaneously or result from a stimulus, usually trauma. When clinical suspicion exists, measurement of the C4 level screens for the disease. An assay showing low serum C1 INH function confirms the diagnosis. When disease severity warrants, symptoms can be controlled with anabolic steroids or antifibrinolytics. Doses should be increased before symptom-provoking events. Emergencies are treated with plasma infusions, fluids, and pain control. Where available, C1 INH concentrate is the treatment of choice. Therapy can usually be monitored by control of symptoms. With appropriate therapy, most cases remain well controlled.

Adult↗

PubMed1991

Musculoskeletal disorders. When are they caused by hormone imbalance?

Often, the source of a musculoskeletal problem can be traced to an endocrine disorder. For example, carpal tunnel syndrome is not uncommon in patients who are pregnant or have diabetes, hypothyroidism, or acromegaly. Joint problems and arthritis are other common findings in diabetes, pregnancy, and hyperparathyroidism. Muscle weakness or stiffness is seen in both hypothyroidism and hyperthyroidism, and muscle wasting is a characteristic of adrenocorticoid insufficiency. Bone disorders are common with glucocorticoid excess, acromegaly, and hyperparathyroidism. Some presentations are a classic picture of a specific endocrine condition and are readily recognized if the index of suspicion is appropriately high.

Carpal Tunnel Syndrome↗

PubMed1990

Mountain sickness.

Acute mountain sickness (AMS) is a failure to adapt to high altitude. Although some people may be at increased risk, most cases are unpredictable. Much can be done, however, to prevent AMS or limit its severity. Staging ascent, sleeping low, and avoiding overexertion and respiratory depressants are all helpful. For some, drug prophylaxis should be considered. Treatment is based on clinical severity, with descent remaining the primary treatment for severe cases.

Acetazolamide↗